{"id":382479,"date":"2026-04-27T15:30:06","date_gmt":"2026-04-27T10:00:06","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=382479"},"modified":"2026-04-27T18:35:39","modified_gmt":"2026-04-27T13:05:39","slug":"organon-co-acquisition-sun-pharma-holdings-usa","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/","title":{"rendered":"Cyril Amarchand Mangaldas advises Organon & Co., a global healthcare company, in its acquisition by Sun Pharmaceutical Holdings USA, Inc."},"content":{"rendered":"
\n

Cyril Amarchand Mangaldas (“CAM<\/span>”) advised Organon & Co. (NYSE: OGN)<\/span>, a global healthcare company, with diverse portfolio across women’s health, biosimilars, and therapies and products for a wide range of conditions and diseases, in its acquisition by Sun Pharmaceutical Holdings USA, Inc., a U.S. subsidiary of Sun Pharmaceutical Industries Ltd (NSE: SUNPHARMA), the leading pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.<\/p>\n

The transaction team was led by Ruetveij Pandya<\/span>, Partner; and Saloni Shroff<\/span>, Partner; with assistance from Abhilasha Malpani<\/span>, Principal Associate; Sajith Anjickal<\/span>, Chelsea Sawlani<\/span>, Neelanshi Gupta<\/span>, Simran Srivastava<\/span>, and Shravan Subramanian<\/span>, Associates.<\/p>\n

Rishabh<\/span> Shroff<\/span>, Partner (Co-Head – Private Client and Head – International Business Development); provided strategic inputs and guidance.<\/p>\n

Meeta Kurpad<\/span>, Partner; with support from Manasvin Andra<\/span>, Associate; advised on financing aspects of the transaction.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The transaction marks a significant cross-border healthcare deal involving a global pharmaceutical portfolio spanning women’s health, biosimilars, and specialty therapies.<\/p>\n","protected":false},"author":67011,"featured_media":382535,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[103135,103133,103131,103134,103130,89652,103128,103132,103129,103136],"class_list":["post-382479","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-biosimilars","tag-camlaw","tag-crossborderdeal","tag-globalhealthcare","tag-healthcaredeal","tag-mergersandacquisitions","tag-organon","tag-pharma","tag-sunpharma","tag-womenshealth"],"yoast_head":"\nOrganon & Co. Acquisition by Sun Pharma Holdings USA | CAM Advises<\/title>\n<meta name=\"description\" content=\"Cyril Amarchand Mangaldas advises Organon & Co. on its acquisition by Sun Pharmaceutical Holdings USA in a major cross-border pharmaceutical deal.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cyril Amarchand Mangaldas advises Organon & Co., a global healthcare company, in its acquisition by Sun Pharmaceutical Holdings USA, Inc.\" \/>\n<meta property=\"og:description\" content=\"Cyril Amarchand Mangaldas advises Organon & Co. on its acquisition by Sun Pharmaceutical Holdings USA in a major cross-border pharmaceutical deal.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-27T10:00:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-27T13:05:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/blog-130.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Cyril Amarchand Mangaldas advises Organon & Co., a global healthcare company, in its acquisition by Sun Pharmaceutical Holdings USA, Inc.\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/\"},\"author\":{\"name\":\"Editor\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"headline\":\"Cyril Amarchand Mangaldas advises Organon & Co., a global healthcare company, in its acquisition by Sun Pharmaceutical Holdings USA, Inc.\",\"datePublished\":\"2026-04-27T10:00:06+00:00\",\"dateModified\":\"2026-04-27T13:05:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/\"},\"wordCount\":157,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/blog-130-1.webp\",\"keywords\":[\"biosimilars\",\"camlaw\",\"crossborderdeal\",\"globalhealthcare\",\"healthcaredeal\",\"MergersAndAcquisitions\",\"organon\",\"pharma\",\"sunpharma\",\"womenshealth\"],\"articleSection\":[\"Law Firms News\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/\",\"name\":\"Organon & Co. Acquisition by Sun Pharma Holdings USA | CAM Advises\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/blog-130-1.webp\",\"datePublished\":\"2026-04-27T10:00:06+00:00\",\"dateModified\":\"2026-04-27T13:05:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"Cyril Amarchand Mangaldas advises Organon & Co. on its acquisition by Sun Pharmaceutical Holdings USA in a major cross-border pharmaceutical deal.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/blog-130-1.webp\",\"contentUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/blog-130-1.webp\",\"width\":886,\"height\":590,\"caption\":\"Organon Co acquisition Sun Pharmaceutical Holdings USA\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/04\\\/27\\\/organon-co-acquisition-sun-pharma-holdings-usa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cyril Amarchand Mangaldas advises Organon & Co., a global healthcare company, in its acquisition by Sun Pharmaceutical Holdings USA, Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/author\\\/editor_4\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Organon & Co. Acquisition by Sun Pharma Holdings USA | CAM Advises","description":"Cyril Amarchand Mangaldas advises Organon & Co. on its acquisition by Sun Pharmaceutical Holdings USA in a major cross-border pharmaceutical deal.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/","og_locale":"en_US","og_type":"article","og_title":"Cyril Amarchand Mangaldas advises Organon & Co., a global healthcare company, in its acquisition by Sun Pharmaceutical Holdings USA, Inc.","og_description":"Cyril Amarchand Mangaldas advises Organon & Co. on its acquisition by Sun Pharmaceutical Holdings USA in a major cross-border pharmaceutical deal.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2026-04-27T10:00:06+00:00","article_modified_time":"2026-04-27T13:05:39+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/blog-130.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Cyril Amarchand Mangaldas advises Organon & Co., a global healthcare company, in its acquisition by Sun Pharmaceutical Holdings USA, Inc.","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/#article","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/"},"author":{"name":"Editor","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"headline":"Cyril Amarchand Mangaldas advises Organon & Co., a global healthcare company, in its acquisition by Sun Pharmaceutical Holdings USA, Inc.","datePublished":"2026-04-27T10:00:06+00:00","dateModified":"2026-04-27T13:05:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/"},"wordCount":157,"commentCount":0,"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/blog-130-1.webp","keywords":["biosimilars","camlaw","crossborderdeal","globalhealthcare","healthcaredeal","MergersAndAcquisitions","organon","pharma","sunpharma","womenshealth"],"articleSection":["Law Firms News","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/","url":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/","name":"Organon & Co. Acquisition by Sun Pharma Holdings USA | CAM Advises","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/blog-130-1.webp","datePublished":"2026-04-27T10:00:06+00:00","dateModified":"2026-04-27T13:05:39+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"Cyril Amarchand Mangaldas advises Organon & Co. on its acquisition by Sun Pharmaceutical Holdings USA in a major cross-border pharmaceutical deal.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/blog-130-1.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/blog-130-1.webp","width":886,"height":590,"caption":"Organon Co acquisition Sun Pharmaceutical Holdings USA"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/27\/organon-co-acquisition-sun-pharma-holdings-usa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Cyril Amarchand Mangaldas advises Organon & Co., a global healthcare company, in its acquisition by Sun Pharmaceutical Holdings USA, Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/blog-130-1.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":274876,"url":"https:\/\/www.scconline.com\/blog\/post\/2022\/10\/01\/deal-release-softgel-healthcare-pvt-limited-acquisition-of-a-controlling-stake-by-everstone-capital\/","url_meta":{"origin":382479,"position":0},"title":"Khaitan & Co advises Softgel Healthcare Pvt Limited on acquisition of a controlling stake in Softgel Healthcare Private Limited by Everstone Capital","author":"Bhumika Indulia","date":"October 1, 2022","format":false,"excerpt":"DEAL DETAILS Softgel Healthcare Pvt Limited | Acquisition of a controlling stake by Everstone Capital NO HEADINGS DETAILS 1. \u00a0 Sector Pharmaceuticals manufacturing sector 2. \u00a0 Announcement Date 14-Sep-2022 3. \u00a0 Completion Date 12-Sep-2022 4. \u00a0 Name of Client Softgel Healthcare Pvt Limited 5. \u00a0 Acquirer Details Everstone Capital |\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/10\/MicrosoftTeams-image-102-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/10\/MicrosoftTeams-image-102-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/10\/MicrosoftTeams-image-102-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/10\/MicrosoftTeams-image-102-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/10\/MicrosoftTeams-image-102-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":374579,"url":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/","url_meta":{"origin":382479,"position":1},"title":"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on USD 16.5 Million Acquisition of Unbound Medicine","author":"Rohit Patel","date":"February 4, 2026","format":false,"excerpt":"The transaction involves a 100% stock purchase and strengthens MPS\u2019s global footprint in digital healthcare solutions.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM advises MPS Limited Unbound Medicine Acquisition","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":368166,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/","url_meta":{"origin":382479,"position":2},"title":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.","author":"Editor","date":"November 29, 2025","format":false,"excerpt":"Comprising a fresh issue and offer for sale by promoter shareholders. The IPO saw an exceptional overall subscription of 93.71 times, with QIB demand at 213.08 times.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Sudeep Pharma IPO","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":341239,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/02\/13\/cyril-amarchand-mangaldas-acts-as-indian-legal-counsel-to-dr-agarwals-health-care-limited\/","url_meta":{"origin":382479,"position":3},"title":"Cyril Amarchand Mangaldas acts as Indian legal counsel to Dr. Agarwal\u2019s Health Care Limited","author":"Bhumika Indulia","date":"February 13, 2025","format":false,"excerpt":"Cyril Amarchand Mangaldas (\u201cCAM\u201d) acted as the Indian legal counsel to Dr. Agarwal\u2019s Health Care Limited","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Dr. Agarwal\u2019s Health Care Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/02\/Dr.-Agarwals-Health-Care-Limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/02\/Dr.-Agarwals-Health-Care-Limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/02\/Dr.-Agarwals-Health-Care-Limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/02\/Dr.-Agarwals-Health-Care-Limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":377611,"url":"https:\/\/www.scconline.com\/blog\/post\/2026\/03\/07\/cyril-amarchand-mangaldas-advises-bessemer-sukino-healthcare-investment-2\/","url_meta":{"origin":382479,"position":4},"title":"Cyril Amarchand Mangaldas acted as legal counsel for Zenex Animal Health India Private Limited in connection with acquisition of majority stake in Netherlands based VievePharm","author":"Editor","date":"March 7, 2026","format":false,"excerpt":"The transaction involved a combination of primary investment and secondary acquisition from existing investors, including Stakeboat Capital, reflecting continued investor interest in India\u2019s healthcare services sector.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Advises Bessemer Venture Partners","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/blog-45-18.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/blog-45-18.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/blog-45-18.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/blog-45-18.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":381226,"url":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/16\/cam-advises-healthtech-solutions-hma-hts-india-acquisition\/","url_meta":{"origin":382479,"position":5},"title":"CAM advised HealthTech Solutions LLC and its founders in relation to acquisition of HTS India LLP by Health Management Associates, Inc.","author":"Editor","date":"April 16, 2026","format":false,"excerpt":"The deal forms part of HMA\u2019s global acquisition of HealthTech, a leading Medicaid-focused technology and analytics provider.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM HTS India Transaction Advisory","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/blog-2026-04-16T180939.592.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/blog-2026-04-16T180939.592.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/blog-2026-04-16T180939.592.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/blog-2026-04-16T180939.592.webp?resize=700%2C400&ssl=1 2x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/382479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=382479"}],"version-history":[{"count":3,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/382479\/revisions"}],"predecessor-version":[{"id":382536,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/382479\/revisions\/382536"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/382535"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=382479"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=382479"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=382479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}